Arovella Therapeutics Limited (ASX:ALA) Raises $20M to Fund Phase 1 Clinical Trials
Arovella Therapeutics (ASX:ALA) secures $20 million placement, fully funding Phase 1 trials for ALA-101 and advancing its cancer therapy pipeline.
Arovella Therapeutics (ASX:ALA) secures $20 million placement, fully funding Phase 1 trials for ALA-101 and advancing its cancer therapy pipeline.
Blue Energy Limited (ASX:BLU) releases Q4 2024 report highlighting ongoing production testing, financial stability, and progress in legal and exploration activities.
Lincoln Minerals Limited (ASX:LML) announces December 2024 quarterly activities, focusing on project advancements and cost reduction strategies.
Andromeda Metals (ASX:ADN) reports Q4 progress on the Great White Project, highlighting funding advancements and government tax incentives.
Peninsula Energy Limited (ASX:PEN) releases its quarterly cash flow report, detailing cash outflows and plans for future funding.
Opthea Limited (ASX:OPT) releases Q2 FY25 Activity Report, detailing advancements in Phase 3 trials and financial developments including a R&D tax incentive.
Emperor Energy (ASX:EMP) releases its December 2024 quarterly report, highlighting share placement and progress on the Judith-2 Well project.
Althea Group Holdings (ASX:AGH) announces $9.01 million in Q2 receipts, with ongoing governance improvements and operational strides in cannabis.
Kingston Resources Limited (ASX:KSN) reveals a cash inflow of $6.431 million in Q4, reflecting growth in its financial position.
Superior Resources Limited (ASX:SPQ) reports notable progress in exploration, including new gold zones and funding for drilling initiatives.